Serum potassium level and mineralocorticoid receptor antagonist dose in a large cohort of chronic heart failure patients

AIMS: Hyperkalaemia is observed frequently in heart failure (HF) patients and is associated with an impaired prognosis and underuse of mineralocorticoid receptor antagonists (MRAs). However, the effects of serum potassium on prescription of the full guideline recommended daily dose of 50 mg in real‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Clephas, Pascal R. D., Radhoe, Sumant P., Linssen, Gerard C. M., Langerveld, Jorina, Plomp, Jacobus, Smits, Jeroen P. P., Nagelsmit, Michiel J., Rocca, Hans‐Peter Brunner‐La, Brugts, Jasper J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053159/
https://www.ncbi.nlm.nih.gov/pubmed/36738129
http://dx.doi.org/10.1002/ehf2.14285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053159/
https://www.ncbi.nlm.nih.gov/pubmed/36738129
http://dx.doi.org/10.1002/ehf2.14285

Ejemplares similares